Published in Immunol Today on October 01, 1990
Human immunodeficiency virus infection induces both polyclonal and virus-specific B cell activation. J Clin Invest (1992) 1.84
Progressive immune dysfunction in cats experimentally infected with feline immunodeficiency virus. J Virol (1991) 1.83
Markers predicting progression of human immunodeficiency virus-related disease. Clin Microbiol Rev (1994) 1.19
Envelope glycoproteins of human immunodeficiency virus type 1: profound influences on immune functions. Microbiol Rev (1996) 1.13
CD40 ligand (CD154) incorporated into HIV virions induces activation-induced cytidine deaminase (AID) expression in human B lymphocytes. PLoS One (2010) 1.09
Early stages of simian immunodeficiency virus infection in lymph nodes. Evidence for high viral load and successive populations of target cells. Am J Pathol (1994) 1.07
Human immunodeficiency virus type 1 envelope glycoproteins gp120 and gp160 induce interleukin-6 production in CD4+ T-cell clones. J Virol (1991) 1.05
B-cell activation following murine cytomegalovirus infection: implications for autoimmunity. Immunology (1993) 1.02
Serum levels of the chemokine CXCL13, genetic variation in CXCL13 and its receptor CXCR5, and HIV-associated non-hodgkin B-cell lymphoma risk. Cancer Epidemiol Biomarkers Prev (2012) 1.01
Parameters of disease progression in long-term experimental feline retrovirus (feline immunodeficiency virus and feline leukemia virus) infections: hematology, clinical chemistry, and lymphocyte subsets. Clin Diagn Lab Immunol (1997) 1.00
Increased expression of interferon-gamma in hyperplastic lymph nodes from HIV-infected patients. Clin Exp Immunol (1993) 0.96
IgA subclasses in HIV disease: dichotomy between raised levels in serum and decreased secretion rates in saliva. Immunology (1995) 0.94
Polymorphism in the interleukin-4 promoter affects acquisition of human immunodeficiency virus type 1 syncytium-inducing phenotype. J Virol (2000) 0.92
CD4-independent binding of HIV-1 to the B lymphocyte receptor CR2 (CD21) in the presence of complement and antibody. Clin Exp Immunol (1992) 0.89
Effects of combined antiretroviral therapy on B- and T-cell release from production sites in long-term treated HIV-1+ patients. J Transl Med (2012) 0.86
Regulation of JC virus expression in B lymphocytes. J Virol (1994) 0.85
Abnormal CD40 ligand (CD154) expression in human immunodeficiency virus-infected children. Clin Diagn Lab Immunol (2001) 0.83
Association of phenotypic changes in B cell lymphocytes and plasma viral load in human immunodeficiency virus-infected patients. J Clin Immunol (1998) 0.80
Murine immune response to HIV-1 p24 core protein following subcutaneous, intraperitoneal and intravenous immunization. Immunology (1991) 0.80
Transgenic dissection of HIV genes involved in lymphoid depletion. J Clin Invest (1997) 0.79
Frequencies of HIV-reactive B cells in seropositive and seronegative individuals. Clin Exp Immunol (1992) 0.78
Molecular determinants of the human antibody response to HIV-1: implications for disease control. J Clin Immunol (2001) 0.76
B-cell activation and HIV-1 infection. Immunol Today (1991) 0.75
Subversion of the B-cell compartment during parasitic, bacterial, and viral infections. BMC Immunol (2015) 0.75
Immunoglobulin G kappa [IgG kappa] and IgG lambda paraproteinemia in a child with AIDS and response to highly active antiretroviral therapy. Clin Diagn Lab Immunol (2005) 0.75
Immune Activation: Contribution to AIDS-Associated Non-Hodgkin Lymphoma. For Immunopathol Dis Therap (2015) 0.75
Genetic control of the CD4/CD8 T-cell ratio in humans. Nat Med (1995) 2.75
CD4: CD8 ratio and HIV infection: the "tap-and-drain' hypothesis. Immunol Today (1996) 2.19
Antigen detection, virus culture, polymerase chain reaction, and in vitro antibody production in the diagnosis of vertically transmitted HIV-1 infection. AIDS (1991) 1.97
HIV-1-specific B cell activation. A major constituent of spontaneous B cell activation during HIV-1 infection. J Immunol (1989) 1.66
Human immunodeficiency virus type 1 modulates telomerase activity in peripheral blood lymphocytes. J Infect Dis (2000) 1.57
Tumor outgrowth in peripheral blood mononuclear cell-injected SCID mice is not associated with early Epstein-Barr virus reactivation. Leukemia (2003) 1.40
Mitochondrial targeting of the p13II protein coded by the x-II ORF of human T-cell leukemia/lymphotropic virus type I (HTLV-I). Oncogene (1999) 1.34
Spontaneous in vitro production of virus-specific antibody by lymphocytes from HIV-infected subjects. Clin Immunol Immunopathol (1988) 1.30
In-vitro production of HIV-specific antibody in children at risk of AIDS. Lancet (1988) 1.22
Dynamics of viral replication in infants with vertically acquired human immunodeficiency virus type 1 infection. J Clin Invest (1996) 1.20
Expression and characterization of proteins produced by mRNAs spliced into the X region of the human T-cell leukemia/lymphotropic virus type II. Virology (1995) 1.20
Intracellular trafficking of the human immunodeficiency virus type 1 Rev protein: involvement of continued rRNA synthesis in nuclear retention. AIDS Res Hum Retroviruses (1995) 1.19
Functional categories of TP53 mutation in colorectal cancer: results of an International Collaborative Study. Ann Oncol (2006) 1.18
Differential response to the cytopathic effects of human T-cell lymphotropic virus type III (HTLV-III) superinfection in T4+ (helper) and T8+ (suppressor) T-cell clones transformed by HTLV-I. Proc Natl Acad Sci U S A (1986) 1.16
Identification of a 3 kb Alu-mediated BRCA1 gene rearrangement in two breast/ovarian cancer families. Oncogene (1999) 1.14
Evolution of human immunodeficiency virus type 1 in perinatally infected infants with rapid and slow progression to disease. J Virol (1997) 1.10
Acquired immunodeficiency syndrome-related Kaposi's sarcoma regression after highly active antiretroviral therapy: biologic correlates of clinical outcome. J Natl Cancer Inst Monogr (2001) 1.09
Seroprevalence of Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 in several regions of Italy. J Hum Virol (1999) 1.09
Pattern of antibody response against the V3 loop in children with vertically acquired immunodeficiency virus type 1 (HIV-1) infection. AIDS Res Hum Retroviruses (1993) 1.09
Viral phenotype and host-cell susceptibility to HIV-1 infection as risk factors for mother-to-child HIV-1 transmission. AIDS (1995) 1.09
Reduced seroprevalence of Kaposi's sarcoma-associated herpesvirus (KSHV), human herpesvirus 8 (HHV8), related to suppression of Anopheles density in Italy. Med Vet Entomol (2003) 1.08
Vertical transmission of HIV-1: lack of detectable virus in peripheral blood cells of infected children at birth. AIDS (1992) 1.07
Moloney murine leukemia virus tolerance in anti-CD4 monoclonal antibody-treated adult mice. J Immunol (1991) 1.06
Co-receptor usage of HIV-1 primary isolates, viral burden, and CCR5 genotype in mother-to-child HIV-1 transmission. AIDS (2000) 1.05
CD8+ T lymphocytes in the lung of acquired immunodeficiency syndrome patients harbor human immunodeficiency virus type 1. Blood (1995) 1.05
Large genomic deletions inactivate the BRCA2 gene in breast cancer families. J Med Genet (2005) 1.04
HIV-1 induces down-regulation of bcl-2 expression and death by apoptosis of EBV-immortalized B cells: a model for a persistent "self-limiting" HIV-1 infection. Virology (1994) 1.02
Restriction of HIV type 1 infection in macrophages heterozygous for a deletion in the CC-chemokine receptor 5 gene. AIDS Res Hum Retroviruses (1999) 1.00
Human T-lymphotropic virus type I transcriptional regulation by methylation. Cancer Res (1990) 1.00
In vitro studies of HIV-1 infection in thymic lymphocytes: a putative role of the thymus in AIDS pathogenesis. AIDS Res Hum Retroviruses (1990) 1.00
Thymus-marrow cell interaction evaluated by PHA stimulation and graft versus host activity. Nature (1971) 1.00
B cell activation during HIV-1 infection. II. Cell-to-cell interactions and cytokine requirement. J Immunol (1991) 1.00
Live attenuated simian immunodeficiency virus prevents super-infection by cloned SIVmac251 in cynomolgus monkeys. J Gen Virol (1997) 0.98
Inhibition of human T-cell leukemia virus type 2 Rex function by truncated forms of Rex encoded in alternatively spliced mRNAs. J Virol (1997) 0.98
The human T-cell lymphotropic virus type 1 Tof protein contains a bipartite nuclear localization signal that is able to functionally replace the amino-terminal domain of Rex. J Virol (1997) 0.98
The p13II protein of HTLV type 1: comparison with mitochondrial proteins coded by other human viruses. AIDS Res Hum Retroviruses (2000) 0.96
P27kip1 expression is associated with tumor response to preoperative chemoradiotherapy in rectal cancer. Ann Surg Oncol (2001) 0.96
Identification of seven new BRCA1 germline mutations in Italian breast and breast/ovarian cancer families. Cancer Res (1996) 0.95
CD4 and CD8 T lymphocyte inheritance. Evidence for major autosomal recessive genes. Hum Genet (1999) 0.95
Polymerase chain reaction and in-vitro antibody production for early diagnosis of paediatric HIV infection. Lancet (1988) 0.94
Telomerase activity in chronic lymphoproliferative disorders of B-cell lineage. Br J Haematol (1999) 0.93
Perinatal infection by human immunodeficiency virus type 1 (HIV-1): relationship between proviral copy number in vivo, viral properties in vitro, and clinical outcome. J Med Virol (1991) 0.92
Polymorphisms in the CCR5 promoter region influence disease progression in perinatally human immunodeficiency virus type 1-infected children. J Infect Dis (2001) 0.92
Transcriptional block of HTLV-I LTR by sequence-specific methylation. Virology (1991) 0.92
Relationship between the V3 loop and the phenotypes of human immunodeficiency virus type 1 (HIV-1) isolates from children perinatally infected with HIV-1. J Virol (1995) 0.92
Replication and tropism of human immunodeficiency virus type 1 as predictors of disease outcome in infants with vertically acquired infection. J Pediatr (1993) 0.92
Regression of AIDS-related Kaposi's sarcoma following antiretroviral therapy with protease inhibitors: biological correlates of clinical outcome. Eur J Cancer (1999) 0.91
Tumours of the haematopoietic system. IARC Sci Publ (1979) 0.90
Phosphorylation of HIV-1 Rev protein: implication of protein kinase CK2 and pro-directed kinases. Biochem Biophys Res Commun (1996) 0.89
HTLV-I/HTLV-II coinfection in an AIDS patient from São Paulo, Brazil. AIDS Res Hum Retroviruses (2000) 0.89
HIV-1 infection of the thymus: evidence for a cytopathic and thymotropic viral variant in vivo. AIDS Res Hum Retroviruses (1995) 0.89
Differential effects of angiostatin, endostatin and interferon-alpha(1) gene transfer on in vivo growth of human breast cancer cells. Gene Ther (2002) 0.88
Pseudotyping of Moloney leukemia virus-based retroviral vectors with simian immunodeficiency virus envelope leads to targeted infection of human CD4+ lymphoid cells. Gene Ther (1998) 0.88
Lack of association between androgen receptor CAG polymorphism and familial breast/ovarian cancer. Cancer Lett (2001) 0.88
Frequency of a mutated CCR-5 allele (delta32) among Italian healthy donors and individuals at risk of parenteral HIV infection. AIDS Res Hum Retroviruses (1999) 0.88
Synthetic peptides from the principal neutralizing domain of human immunodeficiency virus type 1 (HIV-1) enhance HIV-1 infection through a CD4-dependent mechanism. Virology (1991) 0.87
Myosin isoform expression in rat rhabdomyosarcoma induced by Moloney murine sarcoma virus. J Cancer Res Clin Oncol (1987) 0.87
B-cell activation during HIV-1 infection. III. Down-regulating effect of mitogens. AIDS (1991) 0.87
Association of p53 gene and protein alterations with metastases in colorectal cancer. Am J Surg Pathol (1995) 0.87
Infection of Epstein-Barr virus-transformed lymphoblastoid B cells by the human immunodeficiency virus: evidence for a persistent and productive infection leading to B cell phenotypic changes. Eur J Immunol (1990) 0.87
Age dependence and genetics of expression of ecotropic murine leukemia virus in SJL/J mice. J Natl Cancer Inst (1979) 0.86
Nucleotide sequence and restriction fragment-length polymorphism analysis of human T-cell lymphotropic virus type II (HTLV-II) in southern Europe: evidence for the HTLV-IIa and HTLV-IIb subtypes. J Acquir Immune Defic Syndr Hum Retrovirol (1996) 0.86
Influence of Rex and intronic sequences on expression of spliced mRNAs produced by human T cell leukemia virus type I. AIDS Res Hum Retroviruses (1999) 0.85
Gene therapy of ovarian cancer with IFN-alpha-producing fibroblasts: comparison of constitutive and inducible vectors. Gene Ther (2006) 0.85
Spontaneous lymphomas in SJL/J-(v+) mice: ecotropic and dualtropic virus expression in normal and lymphomatous tissues. J Natl Cancer Inst (1981) 0.85
Diagnosis of human immunodeficiency virus 1 infection in infants: in vitro production of virus-specific antibody in lymphocytes. Pediatr Infect Dis J (1990) 0.85
Molecular profile of Epstein-Barr virus in human immunodeficiency virus type 1-related lymphadenopathies and lymphomas. Blood (1997) 0.85
Occasional loss of constitutive heterozygosity at 11p15.5 and imprinting relaxation of the IGFII maternal allele in hepatoblastoma. J Cancer Res Clin Oncol (1994) 0.85
HIV load in highly purified CD8+ T cells retrieved from pulmonary and blood compartments. J Leukoc Biol (1998) 0.85
HTLV-I and HTLV-II infections among HIV-1 seropositive patients in Sao Paulo, Brazil. Eur J Epidemiol (1994) 0.85
Detection of human herpesvirus 8 in cervicovaginal secretions and seroprevalence in human immunodeficiency virus type 1-seropositive and -seronegative women. J Infect Dis (1999) 0.85
[Effect of the age factor on the development of malignant lymphomas and hepatomas in Swiss mice treated with urethane (ethyl carbamate)]. Boll Soc Ital Biol Sper (1964) 0.84
Effects of CD2 locus control region sequences on gene expression by retroviral and lentiviral vectors. Blood (2001) 0.84
Immune reactivity in the Moloney strain of murine sarcoma virus oncogenesis: requirement of thymus-derived lymphocytes for in vivo protection. J Natl Cancer Inst (1976) 0.84
Time course of antigenaemia and seroconversion in infants with vertically acquired HIV-1 infection. AIDS (1993) 0.84
Mechanism of action of the monosialoganglioside GM1 as a modulator of CD4 expression. Evidence that GM1-CD4 interaction triggers dissociation of p56lck from CD4, and CD4 internalization and degradation. J Biol Chem (1993) 0.83
B cell activation and HIV infection: protective or potentially detrimental response? Int Rev Immunol (1992) 0.83
Onset of HIV-1 antibody production after highly active antiretroviral therapy in a seronegative HIV-1-infected child. AIDS (2000) 0.83
Abelson murine leukemia virus-induced thymic lymphomas: transformation of a primitive lymphoid precursor. J Natl Cancer Inst (1987) 0.83
Moloney murine sarcoma virus oncogenesis in T-lymphocyte-deprived mice: biologic and immunologic studies. J Natl Cancer Inst (1980) 0.83
Block of a mitochondrial-mediated apoptotic pathway in Tax-expressing murine fibroblasts. Exp Cell Res (2001) 0.83
Human monoclonal antibody against a gag-coded protein of human immunodeficiency virus produced by a stable EBV-transformed cell clone. AIDS Res Hum Retroviruses (1989) 0.83
T lymphocyte tolerance and early appearance of virus-induced cell surface antigens in Moloney-murine leukemia virus neonatally injected mice. J Immunol (1981) 0.83
Genital human papillomavirus types in immunocompetent and immunodepressed women in northeast Italy: prevalence and cytomorphological correlations. J Low Genit Tract Dis (2001) 0.83
Effects of angiostatin gene transfer on functional properties and in vivo growth of Kaposi's sarcoma cells. Cancer Res (2001) 0.82
Analysis of Tax-expressing cell lines generated from HTLV-I tax-transgenic mice: correlation between c-myc overexpression and neoplastic potential. Exp Cell Res (1999) 0.82
Identification of MIP-1 alpha/LD78 as a monocyte chemoattractant released by the HTLV-I-transformed cell line MT4. AIDS Res Hum Retroviruses (1995) 0.82
The e19a2 BCR/ABL fusion transcript with additional chromosomal aberrations on a new case of chronic myeloid leukemia (CML) of mild type. Leukemia (2001) 0.82
Secondary in vitro generation of cytolytic T-lymphocytes (CTL's) in the murine sarcoma virus system. Virus-specific CTL induction across the H-2 barrier. J Natl Cancer Inst (1978) 0.82
Central nervous system involvement in HIV infection. AIDS Res Hum Retroviruses (1988) 0.82
Bone marrow myeloid cell kinetics during treatment of small cell carcinoma of the lung with chemotherapy not associated and associated with granulocyte-macrophage colony-stimulating factor. Ann Hematol (1993) 0.82
Effect of endogenous and exogenous murine leukemia virus infection on immunologic response. Eur J Cancer (1975) 0.82
Hepatitis C virus infection associated with human hepatocellular carcinoma: lack of correlation with p53 abnormalities in Caucasian patients. Cancer (1998) 0.82